Abstract
The somatomedins (SM’s) are a group of growth-hormone-dependent insulin-like growth factors (IGF’s). The measurement of plasma concentrations of SM-C (IGF-I) in particular appears to have the greatest potential in clinical diagnosis, e.g. to assess growth hormone (GH) status in children; its level is more stable than that of GH, for reasons that are outlined.
The development of assay methodology has progressed from bioassay through receptor assay to immunoassay (Ik) as sufficient amounts of purified hormone became available to permit the production of antibodies (kb’s). The purified hormone being scarce, there is an alternative approach to kb production involving the use of synthetic fragments as immunogens. The resulting kb’s may exhibit sufficient cross-reaction with the whole peptide to permit the measurement of plasma SM-C levels in normal and acromegalic subjects. However, for adequate discrimination between normal and subnormal levels in young children, greater sensitivity is required. So far this has been achieved only with kb’s raised against the whole peptide. Variable interference by SM-binding proteins in Ik methods may necessitate the initial extraction of samples in order to standardize procedures.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Blundell, T.L., Bedarkar, S., Rinderknecht, E. & Humbel, R.E. (1978) Proc. Nat. Acad. Sci. 75, 180–184.
Winegrad, A.J., Shaw, W.N., Lukens, F.D.W., Stadie, W.C. & Renold, A.E. (1959) J. Biol. Chem. 234, 1922–1928.
Froesch, E.R., Burgi, H., Ramseier, E.B., Bally, P. & Labhart, A. (1963) J. Clin. Invest. 42, 1816–1834.
Daughaday, W.H., Hall, K., Raben, M.S., Salmon, W.D., Van den Brande, J.L. & Van Wyk, J.J. (1972) Nature 235, 107.
Van Wyk, J.J., Svoboda, M.E. & Underwood, L.E. (1980) J. Clin. Endocrinol, Metab. 50, 206–208.
Underwood, L.E., D’Ercole, A.J. & Van Wyk, J.J. (1980) Fed. Clin. N. Am. 27, 771–782.
Zapf, J., Schmid, C. & Froesch, E.R. (1984) in Clinics in Endocrinology and Metabolism, Vol. 13, Part 1: Tissue Growth Factors (Daughaday, W.H., ed.), W.B. Saunders, London, pp. 3–30.
Salmon, W.D. & Daughaday, W.H. (1957) J. Lab. Clin. Med. 49, 825–836.
Daughaday, W.H. & Reeder, C. (1966) J. Lab. Clin. Med. 68, 357–368.
Hall, K. & Uthne, K. (1971) Acta Med. Scand. 190, 137–143.
Durlak, N.C. & Temin, H.M. (1973) J. Cell Physiol. 81, 153–160.
Hintz, R.L., Clemmons, D.R., Underwood, L.E. & Van Wyk, J.J. (1972) Proc. Nat. Acad. Sci. 69, 2351–2353.
D’Ercole, A.J., Underwood, L.E., Van Wyk, J.J., Decedue, C.J. & Foushee, D.B.(1976) in Growth Hormone and Related Peptides (Pecile, A. & Muller, E.E., eds.), Excerpta Medica, Amsterdam, pp. 190–201.
Marshall, R.N., Underwood, L.E., Voina, S.J., Foushee, D.B. & Van Wyk, J.J. (1974) J. Clin. Endocrinol. Metab. 39, 283–292.
D’Ercole, A.J., Underwood, L.E. & Van Wyk, J.J. (1977) J. Paed. 90, 375–381.
Zapf, J., Walter, H. & Froesch, E.R. (1981) J. Clin. Invest. 68, 1321–1330.
Hintz, R.L. (1984) as for 7., pp. 31–42.
Rudman, D.J., Kutner, M.H., Blackston, D.R., Cushman, R.A., Bain, R.P. & Patterson, J.H. (1981) New Engl. Med. J. 305, 123–131.
Zapf, J., Kaufmann, V., Eigenmann, E.G. & Froesch, E.R. (1977) Clin. Chem. 23, 677–682.
Zapf, J., Waldvogel, M. & Froesch, E.R. (1975) Arch. Biochem Biophys. 168, 638–645.
Rieu, M., Girard, F., Bricaire, H., & Binoux, M. (1982) J. Clin. Endocrinol. Metab. 55, 147–153.
Svoboda, M.E., Van Wyk, J.J., Klapper, D.G., Fellows, R.E. & Grissom, F.E. (1980) Biochemistry 19, 790–797.
Hintz, R.L., Liu, F., Marshall, L.B. & Chang, D. (1980) J. Clin. Endocrinol. Metab. 50, 405–407.
Hintz, R.L., Liu, F. & Rinderknecht, E. (1980) J.Clin. Endocrinol Metab. 51, 672–673.
Bala, R.M. & Bhaumick, B. (1979) J. Clin. Endocrinol. Metab. 49, 770–777.
Van Wyk, J.J., Svoboda, M.E. & Underwood, L.E. (1980) J. Clin. Endocrinol. Metab. 50, 206–208.
Baxter, R.C., Brown, A.S. & Turtle, J.R. (1982) Clin. Chem. 28, 488–495.
Furlanetto, R.W. (1982) J. Clin. Endocrinol. Metab. 54, 1084–1086.
Daughaday, W.H., Mariz, I.K. & Blethen, S.L. (1980) J. Clin. Endocrinol. Metab. 51, 781–788.
Russo, L. & Moore, W.V. (1982) J. Clin. Endocrinol. Metab. 55, 1003–1006.
Borges, J.L.C., Blizzard, R.M., Evans, W.S., Furlanetto, R., Rogol, A.D., Kaiser, D.L., Rivier, J., Vale, W. & Thorner, M.O. (1984) J. Clin. Endocrinol. Metab. 59, 1–6.
Phillips, L.S. & Unterman, T.G. (1984) as for 7., pp. 145–189.
Clemmons, D.R. & Van Wyk, J.J. (1984) as for 7., pp. 113–143.
Ashton, I.K., Dornan, T.L., Pocock, A.E., Turner, R.C. & Bron, A.J. (1983) Clin. Endocrinol. 19, 105–110.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Teale, J.D., Marks, V. (1986). Clinical Assay of Somatomedins by RIA. In: Reid, E., Scales, B., Wilson, I.D. (eds) BIOACTIVE ANALYTES, Including CNS Drugs, Peptides, and Enantiomers. Methodological Surveys in Biochemistry and Analysis, vol 16 A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1892-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1892-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1894-2
Online ISBN: 978-1-4757-1892-8
eBook Packages: Springer Book Archive